# text.div
Generated Narrative: CodeSystem v3-substanceAdminSubstitution

Language: en

Properties

This code system defines the following properties for its concepts

Name | Code | URI | Type | Description
Not Selectable | notSelectable | http://hl7.org/fhir/concept-properties#notSelectable | boolean | Indicates that the code is abstract - only intended to be used as a selector for other concepts
Status | status | http://hl7.org/fhir/concept-properties#status | code | Designation of a concept's state. Normally is not populated unless the state is retired.

Concepts

This case-sensitive code system http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution defines the following codes in a Is-A hierarchy:

Lvl | Code | Display | Definition | Not Selectable | Status

1

_ActSubstanceAdminSubstitutionCode

ActSubstanceAdminSubstitutionCode

Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.

true

active

2

E

equivalent

Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.

active

3

EC

equivalent composition

Substitution occurred or is permitted with another product that is a:

pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester

pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration

Examples:

Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate

Pharmaceutical equivalent: Lisonpril for Zestril

active

4

BC

brand composition

Substitution occurred or is permitted between equivalent Brands but not Generics

Examples:

Zestril for Prinivil

Coumadin for Jantoven

active

4

G

generic composition

Substitution occurred or is permitted between equivalent Generics but not Brands

Examples:

Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)

active

3

TE

therapeutic alternative

Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.

Examples:

ranitidine for Tagamet

active

4

TB

therapeutic brand

Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics

Examples:

Zantac for Tagamet

active

4

TG

therapeutic generic

Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands

Examples:

Ranitidine for cimetidine

active

2

F

formulary

This substitution was performed or is permitted based on formulary guidelines.

active

2

N

none

No substitution occurred or is permitted.

active

# description
Identifies what sort of change is permitted or has occurred between the therapy that was ordered and the therapy that was/will be provided.

# copyright
This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html

# property[].description
Indicates that the code is abstract - only intended to be used as a selector for other concepts

# property[].description
Designation of a concept's state. Normally is not populated unless the state is retired.

# concept[].definition
Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.

# concept[].concept[].definition
Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.

# concept[].concept[].concept[].definition
Substitution occurred or is permitted with another product that is a:

 *  pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester
 *  pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration

*Examples:* 

 *  *Pharmaceutical alternative:* Erythromycin Ethylsuccinate for Erythromycin Stearate
 *  *Pharmaceutical equivalent:* Lisonpril for Zestril

# concept[].concept[].concept[].concept[].definition
Substitution occurred or is permitted between equivalent Brands but not Generics

*Examples:* 

 *  Zestril for Prinivil
 *  Coumadin for Jantoven

# concept[].concept[].concept[].concept[].definition
Substitution occurred or is permitted between equivalent Generics but not Brands

*Examples:* 

 *  Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)

# concept[].concept[].concept[].definition
Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.

*Examples:* 

 *  ranitidine for Tagamet

# concept[].concept[].concept[].concept[].definition
Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics

>

*Examples:* 

 *  Zantac for Tagamet

# concept[].concept[].concept[].concept[].definition
Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands

>

*Examples:* 

 *  Ranitidine for cimetidine

# concept[].concept[].definition
This substitution was performed or is permitted based on formulary guidelines.

# concept[].concept[].definition
No substitution occurred or is permitted.